NCT02237794
Unknown
Not Applicable
Effect of Medical Treatment on Longitudinal Function of the Heart
ConditionsHeart Function
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Heart Function
- Sponsor
- Hillel Yaffe Medical Center
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Longitudinal Myocardial Function
- Last Updated
- 11 years ago
Overview
Brief Summary
The purpose of this study is to determine the effect of medical treatment on longitudinal myocardial function. Patients who have been hospitalized for reasons other than heart disease will be examined with Transthoracic Cardiography before and after medical treatment to determine change in myocardial function.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Hospitalized patients receiving above-mentioned medications
Exclusion Criteria
- •Patients suffering from heart conditions
- •Patients unable to undergo Echocardiography
- •Pregnancy
Outcomes
Primary Outcomes
Longitudinal Myocardial Function
Time Frame: Two Years
Analysis of longitudinal contractility of the heart by the calculation of the heart's strain factor before and after chronic medication treatment.
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary HyperparathyroidismSecondary HyperparathyroidismMyocardial DysfunctionNCT06187480Mersin University37
Withdrawn
Not Applicable
Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave TherapyCoronary Heart Disease (CHD)NCT01631409City Hospital No 40, Saint Petersburg, Russia
Active, not recruiting
Not Applicable
A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)MyocarditisNCT06189053ModernaTX, Inc.1,500
Recruiting
Not Applicable
Characterization and Prognostic Role of Myocardial Injury in Patients With COVID-19. The CardioCOVID Gemelli Study.Myocardial InjuryCOVID-19NCT05392088Fondazione Policlinico Universitario Agostino Gemelli IRCCS1,500
Completed
Phase 3
Long-term Clinical and Biological Evaluation of Patients With Severe Forms of Pemphigus Treated by RituximabPemphigusNCT01299857University Hospital, Rouen22